TREC@TAMU Cancer Prevention Registry and Repository
Launched by TEXAS A&M UNIVERSITY · Feb 11, 2025
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
The TREC@TAMU Cancer Prevention Registry and Repository study is focused on understanding how health and genetic information can help in preventing and treating cancer. The goal is to gather valuable data from individuals to develop better strategies for cancer care. This study is currently recruiting participants, and it welcomes people aged 18 and older, especially those who are involved in cancer screening programs at specific clinics or who have certain health conditions like COPD or liver disease.
If you choose to participate, you will be asked to provide some health information, as well as blood and urine samples for future research. Your health status will be monitored for five years, and the information will be shared with researchers in a way that keeps your identity private. It’s important to know that if you have a serious memory condition like Alzheimer’s disease, or if you don’t want to share your medical information, you won’t be able to participate. This study aims to make a real difference in how we understand and fight cancer, and your involvement could help in that important work.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 18 years of age and older, and,
- • People participating in the Cancer Prevention and Research Institute of Texas (CPRIT) A coordinated cancer screening research program in Bryan and Navasota Family Medicine Clinics and,
- • People with COPD, liver disease, cervical intraepithelial neoplasia (CIN) lesions, having had a colonoscopy or a low dose computed tomography (LDCT) lung scan or cervical exam in the last 12 months or scheduled for one, and,
- • Able to give and comprehend the consent process, and,
- • Able to consent to donate blood and urine samples, genetic material through buccal swabs for future research, and,
- • Able to understand that their specimens, health record, and changes in health status will be followed for a five-year period and shared in deidentified form with the research community, and,
- • All sexes and gender identities.
- Exclusion Criteria:
- • Declines to participate or interact with staff/share their medical status.
- • A diagnosis of Alzheimer's disease or related dementias in a medical record indicates a progressive, debilitating condition that impairs memory, thought processes, and functioning Individuals who are unable or unwilling to provide consent will be excluded
About Texas A&M University
Texas A&M University, a leading research institution located in College Station, Texas, is dedicated to advancing knowledge and innovation in various fields, including health sciences. As a prominent clinical trial sponsor, Texas A&M University leverages its extensive resources and expertise to conduct rigorous research aimed at improving patient outcomes and addressing critical health challenges. The university fosters collaboration among multidisciplinary teams of researchers, clinicians, and students, ensuring a comprehensive approach to clinical trials that emphasizes ethical standards, scientific integrity, and community impact. Through its commitment to advancing medical research, Texas A&M University plays a vital role in the development of novel therapies and interventions.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Bryan, Texas, United States
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported